Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2023-04-26 00:00:00 ET · period of report 2022-01-07 · accession 0000895345-23-000252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-26 | 2022-01-07+ | CLOV | Reynoso Jamie L. | CEO of Medicare Advantage | F - Tax | $1.50 | -64.9K | 1.44M | -4% | -$97.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-01-31 | F | D | 1,281 | $1.33 | 1,420,116 | D | — | — | (F3) Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting of 1/3rd, of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on January 31, 2022 upon the achievement of certain performance criteria. The original grant was timely reported on a Form 4 filed on July 20, 2021. |
| 2 | Common | Class A Common Stock | 2023-01-07 | F | D | 16,369 | $1.01 | 1,421,397 | D | — | — | (F1) Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021. |
| 3 | Common | Class A Common Stock | 2023-03-14 | F | D | 31,455 | $0.93 | 1,388,661 | D | — | — | (F4) Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting, on March 14, 2023, of 25% of the original number of RSUs granted to the Reporting Person on March 14, 2022. The remaining RSUs vest in twelve equal quarterly installments beginning on the date that is three months after March 14, 2023, in each case subject to the continued service of the Reporting Person on each such vesting date. The original grant of RSUs was timely reported on a Form 4 filed on Mach 16, 2022. |
| 4 | Common | Class A Common Stock | 2022-01-07 | F | D | 15,830 | $3.16 | 1,437,766 | D | — | — | (F1) Represents shares of the Issuer's Class A Common Stock that were automatically withheld by the Issuer to cover the Reporting Person's tax obligations upon the vesting of 25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, on each of January 7, 2022 and January 7, 2023. The original grant was timely reported on a Form 4 filed on July 20, 2021. (F2) The number of shares of the Issuer's Class A Common Stock reported as beneficially owned includes an adjustment from the most recent Form 4 filing to reflect 1,281 shares of the Issuer's Class A Common Stock withheld by the Issuer to cover the Reporting Person's tax obligations in connection with a prior vesting event that was reported on a Form 4/A filed on the same date as this Form 4 report. |